Interleukin-6 (IL-6) is a pleiotropic cytokine crucial in both adaptive and innate immunity. Numerous genetic studies have shown association with variants of this gene in a multitude of diseases and phenotypes. Most tests of association have focused on a limited set of promoter polymorphisms, in particular, the À174G4C; however, there are many inconsistencies within and between these studies. We propose that there is a more complex regulatory haplotype extending further upstream of the previously characterised promoter region which will provide a more detailed view of the effect of variation on lL-6 regulation. We have exploited two additional single nucleotide polymorphisms (SNPs) in IL-6 that, when examined as a haplotype with existing markers, show an increased level of association with systemic onset juvenile arthritis in a family-based study. This suggests that the haplotype effect may be more functionally relevant to the disease.
Introduction
The cytokine Interleukin-6 (IL-6) is expressed in many cell types including osteoblasts, hepatocytes, macrophages, B cells, T cells and synoviocytes. It is important in the link between the innate and adaptive immune response, and acts as a growth factor for many cell types especially B cells. IL-6 also stimulates haematopoiesis and is a major inducer of the hepatic acute phase response. The IL-6 gene is regulated mainly at the transcriptional level by regulatory elements in the 5 0 -flanking region. We have previously reported the extent of polymorphism in the first 1.2 kb of the IL-6 promoter. These include the single-nucleotide polymorphisms (SNPs) À597G4A, À572G4C, À174G4C and a variable AnTn tract at À392 to À373. Haplotypes have been constructed, none of which were found to be associated with systemic arthritis (SA), a subgroup of juvenile idiopathic arthritis in a case-control analysis. 1, 2 However, analysis of the À174G4C polymorphism in both case-control and transmission disequilibrium test (TDT) confirmed that G allele is associated with increased susceptibility to SA. 1, 2 This is in keeping with clinical findings that high serum IL-6 correlates with active disease and fever. [3] [4] [5] Since our first report, this variant has been associated with numerous diseases including type I and II diabetes mellitus, 6, 7 SLE, 8 Sjögren's syndrome, 9 bone density and osteoporosis, [10] [11] [12] Alzheimer disease 13 and coronary heart disease. [14] [15] [16] The candidate gene approach has been widely used to analyse possible associations between genetic variants and autoimmune and inflammatory diseases, with the selection of genes by investigators based on a priori knowledge of disease pathogenesis and phenotypes. However, both linkage analysis and association studies typically leave open the question of whether a diseaseassociated genetic variant is functionally important or serving only as a genetic marker with the functional locus coinherited on the polymorphic allele. In vitro evidence using transient transfection of reporter constructs has suggested a functional role for this À174G4C variant in influencing levels of IL-6 gene expression. 1, 17 Transfection studies revealed differential expression between the two alleles in HeLa cells, with the G allele achieving an overall higher rate of transcription. 1 There is also evidence that different promoter haplotypes including the polymorphic AnTn tract affect gene expression in a cell-specific manner. 1, 16 However, there are numerous inconsistencies within and between these studies concerning the effect that these polymorphisms have on gene expression, particularly which IL-6 À174 genotype is associated with high levels of IL-6. This may be indicative of disease-specific and/or tissue-specific regulation of IL-6 expression. However, it may also suggest a more complex regulatory haplotype extending further upstream of the previously analysed promoter region.
Here, we report the use of two additional polymorphisms upstream of the previously characterised region at À1363 G4T and À1480[CT] in/del, respectively (http:// pga.gs.washington.edu/). These variants have now been analysed for association with SA. A TDT study using 103 simplex families with SA was used to test for association of either the single variants at À1480, À1363 or haplotypes with SA.
Methods
DNA samples were obtained from 103 SA patients and one of or both parents. The diagnoses were made according to ILAR criteria. 18 Ethics approval was obtained from the participating institutions and informed consent obtained from parents and/or child.
Genotyping of the À174 nucleotide variant was carried out by heteroduplex analysis as described previously 19 or allelic discrimination on the ABI PRISM 7000 (Applied Biosystems) with Taqmans probes. 2 The À1480[CT] in/ del, À1363 G4T, À597G4A and À572G4C were genoptyped using Pyrosequencing (protocol available online http://www.pyrosequencing.com). The sequencing primer for the À1480 was designed such that the terminal residue hybridised one base from the polymorphic site. The sequencing primer was also used as the forward primer for PCR, with the biotinylated reverse primer amplifying a 178 bp fragment. This same PCR product was also used to genotype the À1363 G4T SNP using a forward sequencing primer. Primers were similarly designed for SNPs À597G4A and À572G4C, generating 112 and 88 bp PCR products, respectively.
Association studies were performed using the TDT, which tests the preferential transmission of a specific allele from parent to an affected offspring. The TDT tests for association in the presence of linkage and is therefore robust to population stratification. TDT analysis was performed using the programme Transmit 20 that additionally infers missing parental genotypes. GOLD 21 was used to estimate haplotype frequencies and test for linkage disequilibrium.
Results and discussion
The genotype distribution for the parents and patients for all five markers examined was as expected for Hardy-Weinberg equilibrium. The minor allele frequencies for the two novel and three previously characterised polymorphisms are shown in Table 1 . TRANSMIT analysis showed no significant association of any single polymorphism with SA in this cohort. However, haplotype analysis shows a significant distortion in the distribution of the haplotypes, revealing a significant association. TDT results for the common haplotypes (45%) show transmission distortions from heterozygous parents, with P-values from w 2 statistics and bootstrap analysis based on simulations of 10 000 individuals (Tables 2 and 3 ).
The haplotype of all five markers (À174/À572/À597/ À1363/À1480) shows a trend towards association. It has a significant global bootstrap P-value (0.04) with a significant w 2 value for the overtransmission of the À174G/À572G/À597G/À1363G/À1480CT haplotype (P ¼ 0.04). Careful examination of these findings indicates that the haplotypes À174G/À572G/À597G/À1363G/ À1480CT and À174G/À572G/À597A/À1363G/À1480CT are both over-represented in the affected individuals, even though the P-value is not significant for the second variant. This suggests that a disease-associated haplotype is split by the À597 SNP, thus reducing the overall level of significance. This was confirmed by the analysis of the four-marker haplotype À174/À572/À1363/À1480, which shows a significant global transmission distortion in patients (bootstrap P-value o0.0001) with an increase in the transmission of the À174G/À572G/À1363G/ À1480CT haplotype to affected offspring (bootstrap P-value ¼ 0.0007).
It is of interest that the there is a high degree of linkage disequilibrium between markers À174G4C, À597G4A and À1480[CT] (Table 4) . While the incorporation of À1480[CT] with the existing associated marker haplotype adds significance to the finding by refining the associated haplotype, the delta values for these SNPs are marginal for deselecting as tagging SNPs in association studies.
Our previous TDT analysis of IL-6 in SA showed significant association with À174G only when the UK cohort was combined with a US cohort to reach a total of 286 informative transmissions. 2 The most likely explanation for this result is that there was insufficient power to detect association for the single marker in the UK cohort alone. In our current study, the UK families revealed no significant association with SA with any single locus, as was expected from power calculations. However, analysis of haplotype transmission in these families showed evidence for a significant association with SA. This suggests that the haplotype effect may be more functionally relevant to the disease. Whether the À174G4C variant acts independently of the À572C4G, À1480 [CT] and À1363G4C polymorphisms is yet to be determined.
We propose that the large number of association studies conducted using only the single IL6 À174G4C variant provide a limited view of the functional variation responsible for lL-6 expression levels. 22 Indeed, the novel four-marker haplotype we describe here may only represent a partial elucidation of the complex regulation of IL-6, with additional upstream control regions remaining to be characterised. The IL-6 À174G4C, À572G4C, À1363G4T and À1480[CT] polymorphisms In summary, our results clearly illustrate the importance of haplotypic analyses for disease associations, and that single SNP analyses are likely to provide contradictory results. We advocate that future studies involving polymorphic candidate genes should be conducted on comprehensively characterised haplotypes across the gene. 
